
0.0435 Delayed Data As of Jan 27 | ![]() Today’s Change | 0.04 Today|||52-Week Range 8.04 | -32.03% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +4,037.93% increase from the last price of 0.04.
The current consensus among 1 polled investment analysts is to Buy stock in Evofem Biosciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.